Evidence map›Paper›PMID 24434004›Full record

ArticleArchives of biochemistry and biophysics2014

Conformational changes involving ammonia tunnel formation and allosteric control in GMP synthetase.

Justin C Oliver, Ravidra Gudihal, John W Burgner, Anthony M Pedley, Alexander T Zwierko, V Jo Davisson, Rebecca S Linger

Abstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Justin C OliverDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States.
Ravidra GudihalDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States.
John W BurgnerBindley Bioscience Center, Purdue University, West Lafayette, IN 47907, United States.
Anthony M PedleyDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States.
Alexander T ZwierkoDepartment of Pharmaceutical and Administrative Sciences, University of Charleston, Charleston, WV 25304, United States.
V Jo DavissonDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States.
Rebecca S LingerDepartment of Pharmaceutical and Administrative Sciences, University of Charleston, Charleston, WV 25304, United States. Electronic address: rebeccalinger@ucwv.edu.
Purdue University West Lafayette · USUniversity of Charleston · US

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
WVU &MU NEW FACULTY GRANTSP20RR016477 · NCRR · MARSHALL UNIVERSITY · PI RANKIN, GARY O · 2001 to 2011
$35.5M
BIOPHYS STUD OF PROTEINS, NUCLEIC ACIDS, AND VIRUSEST32GM008296 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI STAUFFACHER, CYNTHIA VIANNE · 1989 to 2012
$2.2M
Structures and Mechanisms of Glutamine Dependent EnzymesR01GM067195 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI DAVISSON, VINCENT JO · 2003 to 2006
$1.0M
NCRR NIH HHS P20 RR016477NCRR NIH HHS P20RR016477NIGMS NIH HHS GM067195NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P20GM103434NIGMS NIH HHS R01 GM067195NIGMS NIH HHS T32 GM008296NIGMS NIH HHS T32GM008296
6 · The paper itself

Abstract

GMP synthetase is the glutamine amidotransferase that catalyzes the final step in the guanylate branch of de novo purine biosynthesis. Conformational changes are required to efficiently couple distal active sites in the protein; however, the nature of these changes has remained elusive. Structural information derived from both limited proteolysis and sedimentation velocity experiments support the hypothesis of nucleotide-induced loop- and domain-closure in the protein. These results were combined with information from sequence conservation and precedents from other glutamine amidotransferases to develop the first structural model of GMPS in a closed, active state. In analyzing this Catalytic model, an interdomain salt bridge was identified residing in the same location as seen in other triad glutamine amidotransferases. Using mutagenesis and kinetic analysis, the salt bridge between H186 and E383 was shown to function as a connection between the two active sites. Mutations at these residues uncoupled the two half-reactions of the enzyme. The chemical events of nucleotide binding initiate a series of conformational changes that culminate in the establishment of a tunnel for ammonia as well as an activated glutaminase catalytic site. The results of this study provide a clearer understanding of the allostery of GMPS, where, for the first time, key substrate binding and interdomain contacts are modeled and analyzed.

Indexed as

Allosteric RegulationAmmoniaCarbon-Nitrogen LigasesCatalytic DomainEscherichia coliModels, MolecularMutagenesis, Site-DirectedProtein ConformationProteolysisPurinesAmmoniaCarbon-Nitrogen LigasesGMP synthase (glutamine-hydrolyzing)PurinesAllosteric controlAmmonia tunnelConformational changeGlutamine amidotransferasePurine biosynthesisSubstrate channeling

Identifiers

PMID24434004
PMCPMC3954777
OpenAlexW1964511715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.